A Phase I, open-label, multiple-ascending dose trial to investigate the safety, tolerability, pharmacokinetics, biological and clinical activity of MSB0011359C in subjects with metastatic or locally advanced solid tumors and expansion to selected indications

Type of Cancer
Solid Tumor

Site
Bethesda

Sponsor
EMD Serono Research & Development Institute, Inc.

Protocol Number
EMR 200647-001

To Learn More Call
201-510-0910